2025
SJR Q2
JCR Q3 · 2,6
18 matched articles
SCIE
Journal detail
Drug Testing and Analysis
- Publisher
- John Wiley and Sons Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
1942760319427611
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,712
- Quartile Q2
- H-Index 74
- Cites/doc 2,98
- Docs (3y) 485
- Cites (3y) 1.447
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,6
- 5Y JIF 2,6
- JCI 0,68
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Analytical Chemistry Q2
- Environmental Chemistry Q2
- Pharmaceutical Science Q2
- Spectroscopy Q2
Areas
- Chemistry
- Environmental Science
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Biochemical Research Methods | Chemistry, Analytical | Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,712 | 2,6 | 2,6 | 0,68 | Q2 | 74 |
| 2024 | Q2 | Q2 | 0,623 | 2,7 | 2,7 | 0,76 | Q2 | 71 |
| 2023 | Q1 | Q2 | 0,833 | 2,6 | 2,4 | 0,76 | Q2 | 71 |
| 2022 | Q1 | Q2 | 0,704 | 2,9 | 2,7 | 0,79 | Q2 | 71 |
| 2021 | Q1 | Q2 | 0,878 | 3,2 | 3,1 | 0,84 | Q2 | 71 |
| 2020 | Q1 | Q2 | 1,065 | 3,3 | 3,1 | 0,94 | Q1 | 71 |
| 2019 | Q1 | Q2 | 0,898 | 2,9 | 2,6 | 0,98 | Q1 | 71 |
| 2018 | — | Q2 | — | 2,8 | 2,6 | 1,07 | Q1 | — |
| 2017 | Q1 | Q1 | 0,884 | 3 | 2,6 | 1,06 | Q1 | 71 |
| 2016 | Q1 | Q1 | 1,027 | 3,5 | 2,7 | — | — | 71 |
| 2015 | Q1 | Q1 | 0,8 | 2,9 | 2,4 | — | — | 71 |
| 2014 | Q1 | Q2 | 0,824 | 2,5 | 2,6 | — | — | 71 |
| 2013 | Q1 | Q2 | 0,957 | 2,8 | 2,6 | — | — | 71 |
| 2012 | Q1 | Q2 | 0,806 | 3,3 | 3 | — | — | 71 |
| 2011 | Q1 | Q2 | 0,928 | 2,5 | 2,5 | — | — | 71 |
| 2010 | Q2 | Q3 | 0,352 | 1,7 | 1,7 | — | — | 71 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q3 | Q2 | 47/85 |
| 2025 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | Q2 | 64/110 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 195/356 |
| 2024 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q2 | Q2 | 41/86 |
| 2024 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | Q2 | 56/111 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 164/352 |
| 2023 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q2 | Q2 | 42/85 |
| 2023 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q2 | 53/106 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 173/354 |
| 2022 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q3 | Q2 | 43/77 |
| 2022 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q2 | 41/86 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 163/278 |
| 2021 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q3 | Q2 | 43/79 |
| 2021 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q2 | 41/87 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 164/279 |
| 2020 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q2 | Q2 | 34/78 |
| 2020 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q1 | 34/87 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 144/276 |
| 2019 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q2 | Q2 | 31/77 |
| 2019 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q1 | 30/86 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 120/271 |
| 2018 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q2 | Q2 | 30/79 |
| 2018 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q1 | 28/84 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 115/267 |
| 2017 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q2 | Q2 | 30/79 |
| 2017 | CHEMISTRY, ANALYTICAL | SCIE | Q1 | Q1 | 19/81 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 97/261 |
| 2016 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q2 | — | 25/78 |
| 2016 | CHEMISTRY, ANALYTICAL | SCIE | Q1 | — | 15/76 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 62/257 |
| 2015 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q2 | — | 30/77 |
| 2015 | CHEMISTRY, ANALYTICAL | SCIE | Q1 | — | 18/75 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 86/255 |
| 2014 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q2 | — | 36/79 |
| 2014 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 25/74 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 114/255 |
| 2013 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q2 | — | 28/78 |
| 2013 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 21/76 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 89/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 67/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 104/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 165/252 |